Comparing the Two Top Stocks: Flotek Industries, Inc. (NYSE:FTK), Antares Pharma, Inc. (NASDAQ:ATRS)

earning reaction history, nasdaq, nyse

Flotek Industries, Inc. (NYSE:FTK)

Flotek Industries, Inc. (NYSE:FTK) closed at $2.54 on the last trading session with an increase of 0%, whereas, it previously closed at $2.54. The company has a market capitalization of $182.6 Million. The company traded shares of 302254 on the trading day while its three month average volume stands at 570.29 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Flotek Industries, Inc. (NYSE:FTK) produced diluted EPS of -2.04. The EPS estimate for next year as estimated by analysts is at -0.13 while EPS for next quarter is estimated at -0.08. Earnings per Share growth for this year is reported at -3.6, while the analysts estimated the EPS growth for next year at -0.13% and Earnings growth for next 5 years stands at 10% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -30.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Flotek Industries, Inc. (NYSE:FTK) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Flotek Industries, Inc. (NYSE:FTK) stands at 2.62 and Price to Book or P/B for the most recent quarter stands at 1.54. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Flotek Industries, Inc. (NYSE:FTK) are reported at 3.6 and 4.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Flotek Industries, Inc. (NYSE:FTK) stands at -65.5, -82.6 and -44.4 respectively

The trailing twelve month Revenue of Flotek Industries, Inc. (NYSE:FTK) is reported at 69.7 Million with income of -121900000. The outstanding shares of Flotek Industries, Inc. (NYSE:FTK) are 66.04 Million. The institutional Ownership of the shares of 47.4 stands at 0.80%, this figure is decreased -12.42 in the last six months. The insider ownership for the shares of Flotek Industries, Inc. (NYSE:FTK) is ticked at 5.4%, the figure is rose 38.58% in the last six months.

Some other important financial aspects to be discussed here for Flotek Industries, Inc. (NYSE:FTK) is the Mean Target Price estimated by the analysts which stands at 1.5. The 52 week high of Flotek Industries, Inc. (NYSE:FTK) is placed at 2.88 and 52 week low is standing at 0.66.

Performance wise the shares of Flotek Industries, Inc. (NYSE:FTK) rose up 4.96% for the week, it also rise 59.75% for the monthly performance, while for the quarter it went down 135.19%. The shares increase 203.21% for the half year and flew up for the Year-To-Date performance. The shares of Flotek Industries, Inc. (NYSE:FTK) shrinked -1.55% for the yearly performance.

Antares Pharma, Inc. (NASDAQ:ATRS)

Antares Pharma, Inc. (NASDAQ:ATRS) closed at $2.75 on the last trading session with an decrease of -2.83%, whereas, it previously closed at $2.83. The company has a market capitalization of $455.1 Million. The company traded shares of 894983 on the trading day while its three month average volume stands at 960.65 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Antares Pharma, Inc. (NASDAQ:ATRS) produced diluted EPS of 0.03. The EPS estimate for next year as estimated by analysts is at 0.26 while EPS for next quarter is estimated at 0.02. Earnings per Share growth for this year is reported at 69.9, while the analysts estimated the EPS growth for next year at 0.26% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 45.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Antares Pharma, Inc. (NASDAQ:ATRS) is at 83.33 while the forward p/e is at 10.66. The P/S or Price to Sales ratio of Antares Pharma, Inc. (NASDAQ:ATRS) stands at 3.31 and Price to Book or P/B for the most recent quarter stands at 7.86. The Price to Free Cash Flow ratio or P/FCF is reported at 74.61. The quick ratio and the current ratio of Antares Pharma, Inc. (NASDAQ:ATRS) are reported at 2.4 and 2.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Antares Pharma, Inc. (NASDAQ:ATRS) stands at 4.2, 10.6 and 1 respectively

The trailing twelve month Revenue of Antares Pharma, Inc. (NASDAQ:ATRS) is reported at 137.6 Million with income of 5.6 Million. The outstanding shares of Antares Pharma, Inc. (NASDAQ:ATRS) are 165.7 Million. The institutional Ownership of the shares of 46 stands at 0.80%, this figure is increased 6.84 in the last six months. The insider ownership for the shares of Antares Pharma, Inc. (NASDAQ:ATRS) is ticked at 2.8%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Antares Pharma, Inc. (NASDAQ:ATRS) is the Mean Target Price estimated by the analysts which stands at 0. The 52 week high of Antares Pharma, Inc. (NASDAQ:ATRS) is placed at 5.13 and 52 week low is standing at 1.60.

Performance wise the shares of Antares Pharma, Inc. (NASDAQ:ATRS) rose up 5.36% for the week, it also fell -6.78% for the monthly performance, while for the quarter it went up -5.82%. The shares increase 31.58% for the half year and plummeted for the Year-To-Date performance. The shares of Antares Pharma, Inc. (NASDAQ:ATRS) shrinked -23.4% for the yearly performance.